EGM
PRQR icon

Engineers Gate Manager’s ProQR Therapeutics PRQR Stock Holding History

Engineers Gate Manager’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,730
Closed -$21.9K – 2449
2025
Q2 		$21.9K Buy
+10,730
New +$17.5K ﹤0.01% 2092
2025
Q1 		– Sell
-14,580
Closed -$38.6K – 2487
2024
Q4 		$38.6K Buy
+14,580
New +$46.3K ﹤0.01% 2118

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Engineers Gate Manager's PRQR Position: Q3 2025 in Review

Engineers Gate Manager sold out of ProQR Therapeutics (PRQR) in Q3 2025, closing a stake of 10,730 shares — an estimated $21.9K sold.

Engineers Gate Manager first reported a position in PRQR in Q4 2024 and held it in 2 quarters. The position peaked at $38.6K in Q4 2024. 64 funds tracked by Wall St. Rank hold PRQR as of Q3 2025.

  • Engineers Gate Manager reported no remaining ProQR Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 10,730 ProQR Therapeutics shares in Q3 2025, an estimated $21.9K.
  • Engineers Gate Manager first reported a position in ProQR Therapeutics in Q4 2024 and held it in 2 quarters.
  • Engineers Gate Manager's ProQR Therapeutics position peaked at $38.6K in Q4 2024.
  • 64 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2025.

Based on Engineers Gate Manager's 13F filing for Q3 2025, filed 14 Nov 2025.